Updates From the Crohn’s and Colitis Conference
Three days in Florida resulted in more than just a rosy glow to my cheeks (which was actually due more to a robust, nonstop wind than any hint of sun). Conference information, updates on future research projects, and numerous meetings with the powers that be at pharmaceutical companies resulted in more treatment choices for our patients and community.
So what’s new and upcoming at the Midwest Center for Clinical Research?
Crohn’s suffers can explore new treatment options offered by Bristol Myers Squibb, Glasko Smith Kline, and others. We have oral doing trials, infusion doing trials, and even an exciting phase 1 trial we have high hopes for!
Patients with Ulcerative Colitis can explore new treatments offered by Bristol Myers Squibb and Santuras. And for our patients suffering from IBS we have new options too.
If you are interested in participating or would just like to know more about research reach out to us at info@midwestccr.com or post your thoughts to this blog!
